Expression of BRCA1 protein in breast cancer and its prognostic significance
Authors:
- Emad A. RakhaEmad A. Rakha
- Somaia E. El-SheikhSESomaia E. El-Sheikh
- Mona A. KandilMKMona A. Kandil
- Maysa E. El-SayedMEMaysa E. El-Sayed
- Andrew R. GreenAndrew R. Green
- Ian O. EllisIEIan O. Ellis
- 1 June 2008
- journal article
- Published by Elsevier in Human Pathology
- Vol. 39 (6) , 857-865
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- BRCA1 dysfunction in sporadic basal-like breast cancerOncogene, 2006
- Basal-like breast cancer and the BRCA1 phenotypeOncogene, 2006
- Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiationThe Journal of Pathology, 2006
- High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analysesInternational Journal of Cancer, 2005
- Hallmarks of 'BRCAness' in sporadic cancersNature Reviews Cancer, 2004
- Expression of luminal and basal cytokeratins in human breast carcinomaThe Journal of Pathology, 2004
- Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast CancerJNCI: Journal of the National Cancer Institute, 2003
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991